Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
835 Comparative analysis of pembrolizumab dosing schedule... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
835 Comparative analysis of pembrolizumab dosing schedules in the adjuvant treatment of malignant aelanoma: a real-world experience of 6 weeks versus 3 weeks
0
Authors
Yasar Ahmed
1 more
Yasar Ahmed
•
Diya Sabu
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Cancer
Show all topics
DOI
10.1136/jitc-2024-sitc2024.0835
